Patents by Inventor Hidero Akiyama
Hidero Akiyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8386030Abstract: An iontophoresis device including an active electrode assembly or a counter electrode assembly with a polarizable electrode containing any one of a conductive material having a capacitance per unit weight of 1 F/g or greater, a conductive material having a specific surface area of 10 m2/g or greater, and activated carbon is disclosed. The generation of gas or ions due to an electrode reaction occurring in an electrode assembly may be reduced or prevented. In addition, the alteration of an active agent due to a chemical reaction upon energization may be reduced or prevented.Type: GrantFiled: August 8, 2006Date of Patent: February 26, 2013Assignee: TTI Ellebeau, Inc.Inventors: Kiyoshi Kanamura, Nobuharu Kosiba, Mizuo Nakayama, Takehiko Matsumura, Hidero Akiyama, Akihiko Matsumura
-
Patent number: 8295922Abstract: An iontophoresis device may be capable of preventing or reducing the generation of gas, or the production of undesirable ions, due to an electrode reaction occurring in an electrode assembly; or the alteration of an active agent due to a chemical reaction upon energization. A doping layer made of a substance such as a conductive polymer that effects an electrochemical reaction due to the doping or de-doping of an ion, may be formed in an electrode in an active electrode assembly or counter electrode assembly of an iontophoresis device.Type: GrantFiled: August 7, 2006Date of Patent: October 23, 2012Assignee: TTI ellebeau, Inc.Inventors: Kiyoshi Kanamura, Takehiko Matsumura, Mizuo Nakayama, Hidero Akiyama, Akihiko Matsumura
-
Patent number: 7890164Abstract: An shaped iontophoresis device is capable of permeating an active agent (e.g., a drug solution) into an oral cavity, a skin cancer, or the like by iontophoresis in a pinpoint manner. A catheter-type iontophoresis device includes a small working electrode assembly and a small non-working electrode assembly at the tip of a holding portion. A first ion exchange membrane and a fourth ion exchange membrane at the tips of the assemblies are brought into close contact with a target area so that a drug solution is permeated by iontophoresis in a pinpoint manner. The working electrode assembly and the non-working electrode assembly are attached to the tip of a rod-shaped member. The rod-shaped member is detachable from the tip of the holding portion, and is exchangeable integrally with the portion. The iontophoresis device may advantageously take the form of a rod or catheter.Type: GrantFiled: September 14, 2006Date of Patent: February 15, 2011Assignee: TTI ellebeau, Inc.Inventors: Hidero Akiyama, Mizuo Nakayama, Takehiko Matsumura, Akihiko Matsumura
-
Publication number: 20100100031Abstract: The present invention provides an iontophoresis device with high administration efficient of a drug. An iontophoresis device, including an active electrode structure including: an electrode to which a positive electrical potential is applied; a drug holding part for holding a drug solution containing positively charged drug ions, the drug holding part being placed on a front side of the electrode; a cellulose-based resin film placed on a front side of the drug holding part or a complex film composed of a cation exchange membrane and a cellulose-based resin film placed on a front side of the cation exchange membrane, the complex film being placed on a front side of the drug holding part, in which the drug ions are administered through the cellulose-based resin film.Type: ApplicationFiled: December 21, 2009Publication date: April 22, 2010Applicant: TTI ELLEBEAU, INC.Inventors: Akihiko Tanioka, Mie Minegawa, Kiyoshi Kanamura, Akihiko Matsumura, Mizuo Nakayama, Takehiko Matsumura, Hidero Akiyama
-
Patent number: 7660626Abstract: The present invention provides an iontophoresis device with high administration efficient of a drug. An iontophoresis device, including an active electrode structure including: an electrode to which a positive electrical potential is applied; a drug holding part for holding a drug solution containing positively charged drug ions, the drug holding part being placed on a front side of the electrode; a cellulose-based resin film placed on a front side of the drug holding part or a complex film composed of a cation exchange membrane and a cellulose-based resin film placed on a front side of the cation exchange membrane, the complex film being placed on a front side of the drug holding part, in which the drug ions are administered through the cellulose-based resin film.Type: GrantFiled: August 2, 2005Date of Patent: February 9, 2010Assignee: TTI ellebeau, Inc.Inventors: Akihiko Tanioka, Mie Minagawa, Kiyoshi Kanamura, Akihiko Matsumura, Mizuo Nakayama, Takehiko Matsumura, Hidero Akiyama
-
Publication number: 20100030128Abstract: The transport efficiency of a drug using an iontophoresis device is increased using a negative pressure device. The iontophoresis device includes a working electrode assembly and a non-working electrode assembly for administering drug by iontophoresis. Each of the working electrode assembly and the non-working electrode assembly includes an adhesive surface configured to adhere to a biological interface. A DC electric power source is connected to the working electrode assembly and the non-working electrode assembly. The iontophoresis device further includes a negative pressure device integral with at least one of the working electrode assembly and the non-working electrode assembly and configured to maintain a negative pressure between the at least one of the working electrode assembly and the non-working electrode assembly and the biological interface.Type: ApplicationFiled: September 1, 2006Publication date: February 4, 2010Inventors: Kazuma Mitsuguchi, Mitsugu Yamauchi, Mizuo Nakayama, Takehiko Matsumura, Hidero Akiyama, Akihiko Matsumura
-
Publication number: 20100016781Abstract: An iontophoresis device including an electric power source. A first electrode assembly is electrically coupled to the electric power source to transdermally administer an ionic drug to an organism via iontophoresis while a second electrode assembly is electrically coupled to the electric power source as a counter electrode to the first electrode assembly. A sensor may be positioned proximate an internal or external portion of the organism and operable to determine information used to select and deliver the ionic drug to the organism.Type: ApplicationFiled: August 29, 2006Publication date: January 21, 2010Inventors: Mizuo Nakayama, Takehiko Matsumura, Hidero Akiyama, Akihiko Matsumura
-
Publication number: 20090301882Abstract: An iontophoresis device may include an electrolyte solution holding portion and a drug solution holding portion. The electrolyte solution holding portion holds a solution of an electrolyte that dissociates into a first electrolytic ion of a first polarity type and a second electrolytic ion of a second polarity type in a solution. The drug solution holding portion holds a solution of a drug that dissociates into a drug ion of the first polarity type and a drug counter ion of the second polarity type. The iontophoresis device may also include a first ion exchange membrane with an ion exchange group of the first polarity type and a second ion exchange membrane with an ion exchange group of the second polarity type. The first and the second ion exchange members interpose the electrolyte solution holding portion and the drug solution holding portion.Type: ApplicationFiled: August 1, 2006Publication date: December 10, 2009Inventors: Takehiko Matsumura, Kiyoshi Kanamura, Mizuo Nakayama, Hidero Akiyama, Akihiko Matsumura
-
Publication number: 20090299264Abstract: An iontophoresis device capable of stably holding a drug for a long time period and of transdermally administering the drug at a high transport number during use. The iontophoresis device includes a drug holding portion to store the ionic drug in a dry state and at least an aqueous medium holding portion to store an aqueous medium. The drug holding portion exhibiting ion conductivity in response to a needle inserted into the aqueous medium holding portion from outside the electrode assembly such that the drug holding portion is supplied with the aqueous medium during use and the ionic drug dissolves in the aqueous medium.Type: ApplicationFiled: September 28, 2006Publication date: December 3, 2009Applicant: TTI ELLEBEAU, INC.Inventors: Takehiko Matsumura, Mizuo Nakayama, Hidero Akiyama, Akihiko Matsumura
-
Publication number: 20090299265Abstract: An electrode assembly for iontophoresis including an electrode coupled to an electric power source device having a same polarity as that of the ionic drug in the electrode assembly, an electrolyte solution holding portion holding an electrolyte solution by being impregnated with the electrolyte solution, the electrolyte solution holding portion being placed adjacent to the electrode, a first ion exchange membrane operable to substantially pass ions having a polarity that is same as a polarity of the ionic drug and substantially block ions having a polarity that is opposite the polarity of the ionic drug, the first ion exchange membrane being placed adjacent to the electrolyte solution holding portion, a drug solution holding portion holding the ionic drug by being impregnated with the ionic drug, the drug solution holding portion being placed adjacent to the first ion exchange membrane, a second ion exchange membrane operable to substantially pass ions having a polarity that is opposite the polarity of the ioType: ApplicationFiled: October 2, 2006Publication date: December 3, 2009Applicant: TTI ellebeau, Inc.Inventors: Akihiko Tanioka, Mizuo Nakayama, Takehiko Matsumura, Hidero Akiyama, Akihiko Matsumura
-
Publication number: 20090254018Abstract: An iontophoresis device capable of stably holding a drug during a storage period and of transdermally administering the drug to an organism at a high transport number during use. The iontophoresis device includes an electric power source. A first electrode assembly may be electrically coupled to the electric power source to store and transdermally administer an ionic drug to an organism via iontophoresis. The first electrode assembly stores the ionic drug at a temperature less than or equal to zero degrees Celsius and administers the ionic drug at a temperature greater than zero degrees Celsius. A second electrode assembly may be electrically coupled to the electric power source as a counter electrode to the first electrode assembly.Type: ApplicationFiled: August 24, 2006Publication date: October 8, 2009Inventors: Mizuo Nakayama, Takehiko Matsumura, Hidero Akiyama, Akihiko Matsumura
-
Patent number: 7590444Abstract: An iontophoresis device for administering drug ions via the first ion-exchange membrane, comprising a first semi-permeable film having a number of pores passing through the film from a front surface to a back surface, a first ion-exchange membrane formed of ion-exchange resin filling the pores of the first semi-permeable film and selective ions of a first polarity, and a working electrode structure having a drug holding part placed on a back surface of the first ion-exchange membrane and holding a drug solution containing drug ions charged in the first polarity, wherein a layer of a water-soluble polymer compound is chemically bonded on the surface of the first semi-permeable film.Type: GrantFiled: June 30, 2005Date of Patent: September 15, 2009Assignee: TTI Ellebeau, Inc.Inventors: Akihiko Tanioka, Akihiko Matsumura, Takehiko Matsumura, Mizuo Nakayama, Hidero Akiyama
-
Publication number: 20090221951Abstract: A drug may be administered in accordance with a daily living pattern of a patient and/or a circadian rhythm of the drug. An iontophoresis device includes a working electrode assembly and a non-working electrode assembly for administering a drug by iontophoresis and an electric power source connected to the working electrode assembly and the non-working electrode assembly. Current control circuitry programmably controls a current that flows to each of the electrode assemblies according to a set pattern, and the drug is released based at least in part on the current.Type: ApplicationFiled: September 13, 2006Publication date: September 3, 2009Inventors: Mizuo Nakayama, Takehiko Matsumura, Hidero Akiyama, Akihiko Matsumura
-
Publication number: 20090216177Abstract: A catheter-type iontophoresis device is adapted to cause a drug solution to permeate into a cancer site or the like of a digestive organ on a pinpoint basis by iontophoresis. The catheter-type iontophoresis device includes a working electrode assembly and a non-working electrode assembly for administering a drug by iontophoresis. A DC electric power source is connected to the working electrode assembly and the non-working electrode assembly with opposite polarities, and a rod-like member supports the working electrode assembly and the non-working electrode assembly at its tip. The rod-like member is detachably supported at a tip of a flexible cable supported by an endoscopic device.Type: ApplicationFiled: September 14, 2006Publication date: August 27, 2009Applicant: TTI ellebeau,IncInventors: Hidero Akiyama, Hiroyoshi Kawakami, Mizuo Nakayama, Takehiko Matsumura, Akihiko Matsumura
-
Publication number: 20090214625Abstract: The site to which a patch was stuck may be identified even after the patch is removed. A patch for drug delivery includes a drug holding portion and a backing layer. The patch further includes a marker capable of indicating a site to which the patch was stuck even after the patch is removed therefrom.Type: ApplicationFiled: July 18, 2006Publication date: August 27, 2009Inventors: Mizuo Nakayama, Akihiko Matsumura, Takehiko Matsumura, Hidero Akiyama
-
Publication number: 20090216175Abstract: To provide a transdermal administration device capable of increasing the speed at which a drug is transferred into a skin and the amount of the drug to be transferred into the skin. A transdermal administration device is constituted by: an electrode supplied with a voltage of a first conductivity type; an electrolyte solution holding portion holding an electrolyte solution energized by the electrode; and a bipolar membrane that is placed on the front surface side of the electrolyte solution holding portion, and is composed of a first ion exchange membrane that selectively passes an ion of the first conductivity type and a second ion exchange membrane that selectively passes an ion of a second conductivity type.Type: ApplicationFiled: August 4, 2006Publication date: August 27, 2009Applicant: TRANSCU LTD.Inventors: Takehiko Matsumura, Mizuo Nakayama, Hidero Akiyama, Akihiko Matsumura, Kiyoshi Kanamura, Akihiko Tanioka
-
Publication number: 20090187134Abstract: An iontophoresis device includes an electric power source device, a drug administration device and a current control device. The drug administration device may include at least two or more electrode assemblies each holding an ionic drug. The drug administration device may be coupled to the electric power source device. The current control device may control current flowing to respective ones of the electrode assemblies. An amount of the ionic drug is releasable from each of the electrode assemblies at a defined time when transdermally administered to an organism in accordance with the current flowing from the current control device, wherein at least one of the two or more electrode assemblies holds a sleep-inducing agent as the ionic drug, and at least another one of the two or more electrode assemblies holds a stimulant as the ionic drug.Type: ApplicationFiled: October 2, 2006Publication date: July 23, 2009Inventors: Hidero Akiyama, Mizuo Nakayama, Takehiko Matsumura, Akihiko Matsumura
-
Publication number: 20090171313Abstract: An iontophoresis device transdermally administers an active agent, such as a drug ion, to a biological interface of an organism. The iontophoresis device includes a first electrode assembly having a first electrode member, which is electrically coupled to a terminal, of a main electric power source, having a first polarity that is the same polarity as that of a drug ion. The iontophoresis device includes a drug solution reservoir arranged in an electric field generated by the first electrode member and holding a drug, a counter electrode assembly electrically coupled to another terminal (of the main electric power source) having a second polarity that is opposite to the first polarity, and a vibrating portion having an ultrasonic oscillator for oscillating an ultrasonic wave and an ultrasonic vibrator vibrating due to the ultrasonic wave supplied from the ultrasonic oscillator. The ultrasonic vibrator is provided in the vicinity of the active electrode assembly.Type: ApplicationFiled: December 16, 2008Publication date: July 2, 2009Inventors: Akira Yamamoto, Takehiko Matsumura, Mizuo Nakayama, Hidero Akiyama
-
Patent number: 7437189Abstract: An iontophoresis device includes: a first electrode; a biological interface contact member including a substrate having a front surface and a rear surface, and a plurality of needles that protrude from the front surface of the substrate and can be inserted into a biological interface, the biological interface contact member allowing selective permeation of ions of a first polarity; and a drug holding part applied with an electrical potential or voltage through the first electrode and holding a drug solution containing drug ions charged in the first polarity, the drug holding part being interposed between the first electrode and the biological interface contact member.Type: GrantFiled: August 2, 2005Date of Patent: October 14, 2008Assignee: TTI ellebeau, Inc.Inventors: Akihiko Matsumura, Takehiko Matsumura, Mizuo Nakayama, Hidero Akiyama, Tsutomu Shibata, Akihiko Tanioka
-
Publication number: 20070197955Abstract: An iontophoresis device may include: an electric power source; a first electrode assembly coupled to the electric power source; and a second electrode assembly as a counter electrode of the first electrode assembly. The first electrode assembly may include an adhesive portion that facilitates contact between a mucous membrane and the first electrode assembly. The adhesive portion may be placed on a portion of an end surface portion of an electrode assembly, and may be made from a material that exhibits adhesiveness after absorbing an aqueous medium.Type: ApplicationFiled: October 12, 2006Publication date: August 23, 2007Applicant: TRANSCUTANEOUS TECHNOLOGIES INC.Inventors: Hidero Akiyama, Mizuo Nakayama, Takehiko Matsumura, Akihiko Matsumura